Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Autonomix Medical Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AMIX
Nasdaq
3841
https://autonomix.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Autonomix Medical Inc
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
- Apr 25th, 2024 12:30 pm
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
- Apr 24th, 2024 1:00 pm
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
- Apr 16th, 2024 1:00 pm
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
- Apr 15th, 2024 4:03 pm
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
- Apr 9th, 2024 12:30 pm
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker
- Apr 8th, 2024 12:30 pm
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference
- Mar 27th, 2024 1:00 pm
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024
- Mar 20th, 2024 12:05 pm
Autonomix Appoints Jennifer Cook as Chief Business Officer
- Mar 19th, 2024 12:45 pm
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
- Mar 14th, 2024 12:15 pm
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
- Mar 6th, 2024 1:00 pm
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial
- Feb 29th, 2024 1:30 pm
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity
- Feb 23rd, 2024 1:50 pm
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
- Feb 22nd, 2024 1:00 pm
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
- Feb 16th, 2024 1:00 pm
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones
- Feb 14th, 2024 1:05 pm
Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference
- Feb 9th, 2024 1:45 pm
Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain
- Feb 6th, 2024 1:50 pm
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event
- Feb 1st, 2024 1:35 pm
Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024
- Jan 31st, 2024 1:45 pm
Scroll